松元 美奈子 (マツモト ミナコ)

Matsumoto Minako

写真a

所属(所属キャンパス)

医学部 衛生学公衆衛生学教室 (信濃町)

職名

助教(有期)

経歴 【 表示 / 非表示

  • 2014年04月
    -
    2016年03月

    薬学部, 付属薬局, 薬剤師

  • 2018年04月
    -
    2019年04月

    医学部, 衛生学公衆衛生学教室, 特任助教

  • 2019年05月
    -
    継続中

    医学部, 衛生学公衆衛生学教室, 助教

学歴 【 表示 / 非表示

  • 2008年04月
    -
    2014年03月

    慶應義塾大学, 薬学部, 薬学科

    大学, 卒業

  • 2016年04月
    -
    2018年03月

    慶應義塾大学, 健康マネジメント研究科, スポーツマネジメント専修

    大学院, 卒業, 修士

学位 【 表示 / 非表示

  • 修士(公衆衛生学), 慶應義塾大学, 課程, 2018年03月

免許・資格 【 表示 / 非表示

  • 薬剤師免許, 2014年03月

 

研究分野 【 表示 / 非表示

  • ライフサイエンス / 衛生学、公衆衛生学分野:実験系を含む

  • ライフサイエンス / 衛生学、公衆衛生学分野:実験系を含まない

研究キーワード 【 表示 / 非表示

  • メタボロミクス 予防医学 公衆衛生

  • 薬剤疫学

 

著書 【 表示 / 非表示

論文 【 表示 / 非表示

  • Validity assessment of self-reported medication use for hypertension, diabetes, and dyslipidemia in a pharmacoepidemiologic study by comparison with health insurance claims

    Matsumoto M., Harada S., Iida M., Kato S., Sata M., Hirata A., Kuwabara K., Takeuchi A., Sugiyama D., Okamura T., Takebayashi T.

    Journal of Epidemiology (Journal of Epidemiology)  31 ( 9 ) 495 - 502 2021年

    研究論文(学術雑誌), 単著, 査読有り,  ISSN  1349-9092

     概要を見る

    Background: Although self-reported questionnaires are widely employed in epidemiologic studies, their validity has not been sufficiently assessed. The aim of this study was to evaluate the validity of a self-reported questionnaire on medication use by comparison with health insurance claims and to identify individual determinants of discordance in the Tsuruoka Metabolomics Cohort Study. Methods: Participants were 2,472 community-dwellers aged 37 to 78 years from the Tsuruoka Metabolomics Cohort Study. Information on lifestyle and medications was collected through a questionnaire. Sensitivity and specificity were determined using health insurance claims from November 2014 to March 2016, which were used as a standard. Potential determinants of discordance were assessed using multivariable logistic regression. Results: The self-reported questionnaire on medication use showed high validity. Sensitivity and specificity were 0.95 (95% CI, 0.93–0.96) and 0.97 (95% CI, 0.96–0.98) for antihypertensive medications, 0.94 (95% CI, 0.91–0.97) and 0.98 (95% CI, 0.98–0.99) for diabetes medications, and 0.84 (95% CI, 0.82–0.87) and 0.98 (95% CI, 0.97–0.99) for dyslipidemia medications, respectively. Males without high education and those who currently smoke cigarettes were found to be associated with discordant reporting which affected sensitivity, especially those with medication use for dyslipidemia. Conclusions: In this population-based cohort study, we found that the self-reported questionnaire on medication use was a valid measure to capture regular medication users. Sensitivity for dyslipidemia medications was lower than those for the other medications. Type of medication, sex, education years, and smoking status influenced discordance, which affected sensitivity in self-reporting.

  • The association between sleep parameters and sarcopenia in Japanese community-dwelling older adults

    Shibuki T., Iida M., Harada S., Kato S., Kuwabara K., Hirata A., Sata M., Matsumoto M., Osawa Y., Okamura T., Sugiyama D., Takebayashi T.

    Archives of Gerontology and Geriatrics (Archives of Gerontology and Geriatrics)  109 2023年06月

    ISSN  01674943

     概要を見る

    Purpose: This study aimed to examine the association between sleep duration and quality and sarcopenia, assessed by factors such as low muscle mass (LMM), low muscle strength (LMS), and low physical performance (LPP) among older community-dwellers in Japan. Methods: In this cross-sectional study, a total of 2,069 (men, 902; women, 1,167) participants aged 65 to 80 years were included. Sarcopenia and each low physical function were defined using the definitions of the Asian Working Groups of Sarcopenia 2019. Sleep duration was stratified into three categories: short sleep (<6 h), normal sleep (6-8 h), and long sleep (>8 h). Sleep quality was classified into two groups based on 8-item Athens Insomnia Scale score: insomnia (≥6), and non-insomnia (<6). We analyzed the association between sleep parameters and sarcopenia, including low physical functions, by logistic regression analysis. Results: Compared to normal sleepers, long sleepers had a positive association with sarcopenia (odds ratio [OR] 2.11, 95% confidence interval [CI] 1.25-3.58). In particular, long sleep was strongly associated with LMS (OR 1.77, 95%CI 1.07-2.94) and LPP (OR 1.90, 95%CI 1.25-2.88). On the other hand, poor sleep quality was not associated with sarcopenia in long sleepers, but in normal sleepers. Conclusions: Long sleep was associated with sarcopenia, including LMS and LPP. However, in long sleepers, insomnia was not associated with sarcopenia or any of its components.

  • Accumulated unhealthy behaviours and insomnia in Japanese dwellers with and without cardiovascular risk factors: A cross-sectional study

    Kato S., Harada S., Iida M., Kuwabara K., Sugiyama D., Takeuchi A., Sata M., Matsumoto M., Kurihara A., Hirata A., Okamura T., Takebayashi T.

    BMJ Open (BMJ Open)  12 ( 4 )  2022年04月

     概要を見る

    Objectives To date, the association between accumulated unhealthy behaviours and insomnia in individuals stratified according to the presence or absence of major cardiovascular risk factors is unclear. This study aimed to examine the effect of accumulated unhealthy behaviours on insomnia in Japanese dwellers. Design Cross-sectional study. Setting Baseline data between April 2012 and March 2015. Participants Our study used cross-sectional data among Japanese aged 35-74 years in a rural community (N=9565), the attendees of annual municipal or work site health check-up programmes. Main outcome measures Insomnia was assessed by Athens Insomnia Scale, which was set at 6 points and greater; other scales were given. Participants were categorised into three groups by their number of unhealthy behaviours (no exercise habit, smoking, alcohol drinking, skipping breakfast and obesity): 0-1, 2-3, 4 or more. The association between accumulated unhealthy behaviours and insomnia was estimated by logistic regression analysis. Further analysis was done after stratification of cardiovascular risk factors assessed by anthropometrics and clinical biochemistry measurements. Results The overall prevalence of insomnia was 13.3% for men and 19.3% for women. Men with unhealthy behaviour factors were more likely to have insomnia after adjusting for potential confounders, compared with the least unhealthy group (trend p=0.013). Women with four or more unhealthy behaviour factors were more likely to have insomnia, compared with the lowest groups (OR 1.175, 95% CI 1.077 to 1.282). Insomnia has an association with the unhealthy behaviours among men without cardiovascular risk factors (lowest groups: OR 1.133, 95% CI 1.037 to 1.238, trend p=0.026). Women without hypertension were more likely to have suspected insomnia, compared with the lowest group (OR 1.215, 95% CI 1.101 to 1.341). Conclusion The results showed accumulated unhealthy behaviours were associated with increased risk of insomnia in Japanese dwellers. For healthy population without cardiovascular risk factors, unhealthy behaviours should be considered as background conditions for insomnia.

  • Changes in Smoking Habits and Behaviors Following the Introduction and Spread of Heated Tobacco Products in Japan and Its Effect on FEV<inf>1</inf> Decline: A Longitudinal Cohort Study

    Harada S., Sata M., Matsumoto M., Iida M., Takeuchi A., Kato S., Hirata A., Kuwabara K., Shibuki T., Ishibashi Y., Sugiyama D., Okamura T., Takebayashi T.

    Journal of Epidemiology (Journal of Epidemiology)  32 ( 4 ) 180 - 187 2022年04月

    ISSN  09175040

     概要を見る

    Background: Heated tobacco product (HTP) use in Japan has rapidly increased. Despite this rapid spread, little is known about the health effects of HTP use. We conducted a longitudinal cohort study to investigate the change in smoking habits following the spread of HTP use and its effect on forced expiratory volume in 1 second (FEV1) decline. Methods: Participants consisted of a resident population (n = 2,612; mean age, 67.7 years) with FEV1 measurement in 2012–2014 and 2018–2019, and a worksite population (n = 722; mean age 49.3 years) without FEV1 data. Participants were categorized as combustible cigarette-only smokers, HTP-only users, dual users, past smokers, and never smokers. The association between smoking group and the change in smoking consumption over a mean 5.6 years was examined. Differences in annual FEV1 change between smoking groups were examined in the resident population. Results: Prevalence of HTP-only and dual users in 2018–2019 was 0.8% and 0.6% in the resident population, and 5.0% and 1.9% in the worksite population, respectively. The overall number of tobacco products smoked=used increased in dual users compared to baseline, but not in others. Annual FEV1 decline in dual users tended to be greater than that in cigarette-only smokers (16; 95% confidence interval, −34 to 2 mL=year after full adjustment). Participants switching to HTP-only use 1.7 years before had a similar FEV1 decline as cigarette-only smokers. Conclusions: HTP use, including dual use, is prevalent even in a rural region of Japan. Dual users appear to smoke=use tobacco products more and have a greater FEV1 decline. Tobacco policy should consider dual use as high-risk.

  • Sars-cov-2 infection among medical institution faculty and healthcare workers in tokyo, japan

    Nishimura T., Uwamino Y., Uno S., Kashimura S., Shiraki T., Kurafuji T., Morita M., Noguchi M., Azegami T., Yamada-Goto N., Murai-Takeda A., Yokoyama H., Kuwabara K., Kato S., Matsumoto M., Hirata A., Iida M., Harada S., Ishizaka T., Misawa K., Murata M., Saya H., Amagai M., Kitagawa Y., Takeuchi T., Mori M., Takebayashi T., Hasegawa N.

    Internal Medicine (Internal Medicine)  60 ( 16 ) 2569 - 2575 2021年

    ISSN  09182918

     概要を見る

    Objective To consider effective measures against severe acute respiratory syndrome coronavirus 2 (SARSCoV- 2) infection in medical institutions, this study estimated the SARS-CoV-2 infection rate among healthcare workers (HCWs) in Tokyo, Japan, and determined the specific findings for mild coronavirus disease 2019 (COVID-19) cases. Methods This study analyzed the results of serologic tests to detect immunoglobulin G antibodies against SARS-CoV-2 and evaluated the demographic and clinical characteristics of the faculty and HCWs at a Tokyo medical institution in August 2020. The demographic and clinical characteristics of participants with antibody-positive results were compared to those of participants with antibody-negative results. Materials This study recruited 2,341 faculty and HCWs at a Tokyo medical institution, 21 of whom had a COVID-19 history. Results Of the 2,320 participants without a COVID-19 history, 20 (0.862%) had positive serologic test results. A fever and dysgeusia or dysosmia occurred with greater frequency among the participants with positive test results than in those with negative results [odds ratio (OR), 5.475; 95% confidence interval (CI), 1.960-15.293 and OR, 24.158; 95% CI, 2.693-216.720, respectively]. No significant difference was observed in the positivity rate between HCWs providing medical care for COVID-19 patients using adequate protection and other HCWs (OR, 2.514; 95% CI, 0.959-6.588). Conclusion To reduce the risk of COVID-19 spread in medical institutions, faculty and HCWs should follow standard and necessary transmission-based precautions, and those with a fever and dysgeusia or dysosmia should excuse themselves from work as soon as possible.

全件表示 >>

KOARA(リポジトリ)収録論文等 【 表示 / 非表示

研究発表 【 表示 / 非表示

  • 健診において気流閉塞を認めた地域在住者の実態の検討:鶴岡メタボロームコホート研究

    松元美奈子,原田成,飯田美穂,平田あや,宮川尚子,桑原和代,土岐了大,枝川俊,三宅温子,杉山大典,岡村智教,武林亨

    2023年11月

    ポスター発表

  • Factors associated with failure to undergo secondary examinations after an annual checkup from population-based cohort study(Tsuruoka Metabolomics Cohort Study)

    Minako Matsumoto, Sei Harada, Miho Iida, Aya Hirata, Kazuyo Kuwabara, Naoko Miyagawa, Tomonori Okamura, Toru Takebayashi

    第33回日本医療薬学会年会, 

    2023年11月

    口頭発表(一般)

  • お薬手帳と比較した自記式質問紙による服薬情報の妥当性研究

    矢嶋里菜,松元美奈子,原田成,飯田美穂,平田あや,桑原和代,宮川尚子,中村智徳,岡村智教,武林亨

    第82回日本公衆衛生学会総会, 

    2023年10月
    -
    2023年11月

    ポスター発表

  • 健診における受診勧奨に基づく国保・後期高齢者の二次健診受診要因の検討

    松元美奈子、原田成、飯田美穂、加藤寿寿華、佐田みずき、平田あや、宮川尚子、桑原和代、杉山大典、岡村智教、武林亨

    第33回日本疫学会学術総会 (アクトシティ浜松(浜松市)) , 

    2023年02月

    ポスター発表

  • Evaluation of medication adherence in hypertension and dyslipidemia: population-based cohort study in Japan

    Minako Matsumoto, Sei Harada, Miho Iida, Suzuka Kato, Mizuki Sata, Naoko Miyagawa, Aya Hirata, Kazuyo Kuwabara, Ayano Takeuchi, Daisuke Sugiyama, Tomonori Okamura, Toru Takebayashi

    ISPE's14th Asian Conference on Pharmacoepidemioplogy (Tainan) , 

    2022年10月

    ポスター発表

全件表示 >>

競争的研究費の研究課題 【 表示 / 非表示

  • 健診における受診勧奨に基づく国保・後期高齢者の二次健診受診要因の検討

    2021年10月
    -
    2022年09月

    医療経済研究機構, 松元 美奈子, その他,  研究代表者

  • スタチン使用による糖尿病発症リスクに関するメタボローム疫学研究

    2019年04月
    -
    2020年03月

    文部科学省・日本学術振興会, 科学研究費助成事業, 松元 美奈子, 研究活動スタート支援, 補助金,  研究代表者

  • スタチン使用による糖尿病発症リスクに関するメタボローム疫学研究

    2018年10月
    -
    継続中

    文部科学省・日本学術振興会, 科学研究費助成事業, 松元 美奈子, 研究活動スタート支援, 補助金,  研究代表者

受賞 【 表示 / 非表示

  • 学生優秀発表賞

    幾田 遥史、松元 美奈子、地引 綾、横山 雄太、河添 仁、鈴木 小夜、中村 智徳、武林 亨, 2021年03月, 日本薬学会第141年会, 高齢者における三大生活習慣病と服薬アドヒアランスの検討

    受賞区分: 国内学会・会議・シンポジウム等の賞

  • Spotlight poster presentation

    Minako Matsumoto, Sei Harada, Miho Iida, Tomonori Okamura, Toru Takebayashi, 2019年10月, 12th ISPE ACPE Conference, Validity assessment of self-reported medication use in a pharmacoepidemiology research (by comparing to medical and pharmacy insurance claims)

    受賞区分: 国際学会・会議・シンポジウム等の賞

 

担当授業科目 【 表示 / 非表示

  • 衛生学Ⅰ

    2023年度, 秋学期, 学部専門科目, 講義

  • 衛生学Ⅱ

    2023年度, 秋学期, 学部専門科目, 講義

  • 公衆衛生学Ⅱ

    2023年度, 秋学期, 学部専門科目, 実習・実験

  • メディカル・プロフェッショナリズムⅤ

    2023年度, その他

  • 医学統計・医療情報

    2022年度

全件表示 >>

 

社会活動 【 表示 / 非表示

  • 鶴岡みらい健康づくり活動

    2017年
    -
    継続中

所属学協会 【 表示 / 非表示

  • 日本産業衛生学会, 

    2018年04月
    -
    継続中
  • 日本薬剤疫学会, 

    2018年
    -
    継続中
  • 日本循環器予防学会, 

    2018年
    -
    継続中
  • 日本動脈硬化学会, 

    2018年
    -
    継続中
  • 日本疫学会, 

    2018年
    -
    継続中

全件表示 >>

委員歴 【 表示 / 非表示

  • 2023年12月
    -
    継続中

    日本薬剤疫学会 拡充委員会

  • 2023年08月
    -
    継続中

    日本薬剤疫学会, Webサイトリニューアルタスクフォースの委員